nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Gastric irritation—Aminophylline—chronic obstructive pulmonary disease	0.0541	0.0541	CcSEcCtD
Polythiazide—Epigastric discomfort—Aminophylline—chronic obstructive pulmonary disease	0.0399	0.0399	CcSEcCtD
Polythiazide—Angiitis necrotising—Prednisone—chronic obstructive pulmonary disease	0.0344	0.0344	CcSEcCtD
Polythiazide—Vasculitis necrotising—Prednisone—chronic obstructive pulmonary disease	0.03	0.03	CcSEcCtD
Polythiazide—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.0226	0.0226	CcSEcCtD
Polythiazide—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.0214	0.0214	CcSEcCtD
Polythiazide—Glycosuria—Formoterol—chronic obstructive pulmonary disease	0.0197	0.0197	CcSEcCtD
Polythiazide—Glycosuria—Arformoterol—chronic obstructive pulmonary disease	0.0197	0.0197	CcSEcCtD
Polythiazide—Glycosuria—Salbutamol—chronic obstructive pulmonary disease	0.0186	0.0186	CcSEcCtD
Polythiazide—Gastric irritation—Prednisone—chronic obstructive pulmonary disease	0.0162	0.0162	CcSEcCtD
Polythiazide—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.016	0.016	CcSEcCtD
Polythiazide—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.0132	0.0132	CcSEcCtD
Polythiazide—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.0124	0.0124	CcSEcCtD
Polythiazide—Epigastric discomfort—Prednisone—chronic obstructive pulmonary disease	0.0119	0.0119	CcSEcCtD
Polythiazide—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.0119	0.0119	CcSEcCtD
Polythiazide—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.0112	0.0112	CcSEcCtD
Polythiazide—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.0104	0.0104	CcSEcCtD
Polythiazide—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.0104	0.0104	CcSEcCtD
Polythiazide—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.0102	0.0102	CcSEcCtD
Polythiazide—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00985	0.00985	CcSEcCtD
Polythiazide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00976	0.00976	CcSEcCtD
Polythiazide—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00962	0.00962	CcSEcCtD
Polythiazide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.0096	0.0096	CcSEcCtD
Polythiazide—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00904	0.00904	CcSEcCtD
Polythiazide—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00904	0.00904	CcSEcCtD
Polythiazide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00892	0.00892	CcSEcCtD
Polythiazide—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00886	0.00886	CcSEcCtD
Polythiazide—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00853	0.00853	CcSEcCtD
Polythiazide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00853	0.00853	CcSEcCtD
Polythiazide—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00843	0.00843	CcSEcCtD
Polythiazide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00827	0.00827	CcSEcCtD
Polythiazide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00822	0.00822	CcSEcCtD
Polythiazide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00805	0.00805	CcSEcCtD
Polythiazide—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.00776	0.00776	CcSEcCtD
Polythiazide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00768	0.00768	CcSEcCtD
Polythiazide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00742	0.00742	CcSEcCtD
Polythiazide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00714	0.00714	CcSEcCtD
Polythiazide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00713	0.00713	CcSEcCtD
Polythiazide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00708	0.00708	CcSEcCtD
Polythiazide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00707	0.00707	CcSEcCtD
Polythiazide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00703	0.00703	CcSEcCtD
Polythiazide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00671	0.00671	CcSEcCtD
Polythiazide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00671	0.00671	CcSEcCtD
Polythiazide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00667	0.00667	CcSEcCtD
Polythiazide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00657	0.00657	CcSEcCtD
Polythiazide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00651	0.00651	CcSEcCtD
Polythiazide—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00644	0.00644	CcSEcCtD
Polythiazide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00641	0.00641	CcSEcCtD
Polythiazide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00641	0.00641	CcSEcCtD
Polythiazide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00634	0.00634	CcSEcCtD
Polythiazide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00634	0.00634	CcSEcCtD
Polythiazide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00628	0.00628	CcSEcCtD
Polythiazide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00606	0.00606	CcSEcCtD
Polythiazide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00604	0.00604	CcSEcCtD
Polythiazide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00595	0.00595	CcSEcCtD
Polythiazide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00592	0.00592	CcSEcCtD
Polythiazide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00561	0.00561	CcSEcCtD
Polythiazide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00551	0.00551	CcSEcCtD
Polythiazide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00546	0.00546	CcSEcCtD
Polythiazide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00532	0.00532	CcSEcCtD
Polythiazide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0052	0.0052	CcSEcCtD
Polythiazide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00513	0.00513	CcSEcCtD
Polythiazide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00512	0.00512	CcSEcCtD
Polythiazide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.0051	0.0051	CcSEcCtD
Polythiazide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00501	0.00501	CcSEcCtD
Polythiazide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00495	0.00495	CcSEcCtD
Polythiazide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00487	0.00487	CcSEcCtD
Polythiazide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00487	0.00487	CcSEcCtD
Polythiazide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00483	0.00483	CcSEcCtD
Polythiazide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00476	0.00476	CcSEcCtD
Polythiazide—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00473	0.00473	CcSEcCtD
Polythiazide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00472	0.00472	CcSEcCtD
Polythiazide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00471	0.00471	CcSEcCtD
Polythiazide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00469	0.00469	CcSEcCtD
Polythiazide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00468	0.00468	CcSEcCtD
Polythiazide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00467	0.00467	CcSEcCtD
Polythiazide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.0046	0.0046	CcSEcCtD
Polythiazide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00453	0.00453	CcSEcCtD
Polythiazide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00453	0.00453	CcSEcCtD
Polythiazide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00449	0.00449	CcSEcCtD
Polythiazide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Polythiazide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Polythiazide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Polythiazide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00443	0.00443	CcSEcCtD
Polythiazide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00442	0.00442	CcSEcCtD
Polythiazide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00427	0.00427	CcSEcCtD
Polythiazide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0042	0.0042	CcSEcCtD
Polythiazide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0042	0.0042	CcSEcCtD
Polythiazide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00419	0.00419	CcSEcCtD
Polythiazide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00411	0.00411	CcSEcCtD
Polythiazide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00409	0.00409	CcSEcCtD
Polythiazide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00409	0.00409	CcSEcCtD
Polythiazide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Polythiazide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00396	0.00396	CcSEcCtD
Polythiazide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0039	0.0039	CcSEcCtD
Polythiazide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0039	0.0039	CcSEcCtD
Polythiazide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00386	0.00386	CcSEcCtD
Polythiazide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00386	0.00386	CcSEcCtD
Polythiazide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00382	0.00382	CcSEcCtD
Polythiazide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00377	0.00377	CcSEcCtD
Polythiazide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00377	0.00377	CcSEcCtD
Polythiazide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00369	0.00369	CcSEcCtD
Polythiazide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00368	0.00368	CcSEcCtD
Polythiazide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00362	0.00362	CcSEcCtD
Polythiazide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00362	0.00362	CcSEcCtD
Polythiazide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Polythiazide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Polythiazide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Polythiazide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Polythiazide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Polythiazide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00357	0.00357	CcSEcCtD
Polythiazide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00356	0.00356	CcSEcCtD
Polythiazide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00356	0.00356	CcSEcCtD
Polythiazide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00355	0.00355	CcSEcCtD
Polythiazide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00352	0.00352	CcSEcCtD
Polythiazide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Polythiazide—Headache—Montelukast—chronic obstructive pulmonary disease	0.0035	0.0035	CcSEcCtD
Polythiazide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00342	0.00342	CcSEcCtD
Polythiazide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.0034	0.0034	CcSEcCtD
Polythiazide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Polythiazide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Polythiazide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Polythiazide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Polythiazide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Polythiazide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00331	0.00331	CcSEcCtD
Polythiazide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00319	CcSEcCtD
Polythiazide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Polythiazide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00252	0.00252	CcSEcCtD
Polythiazide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00247	0.00247	CcSEcCtD
Polythiazide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00245	0.00245	CcSEcCtD
Polythiazide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00227	0.00227	CcSEcCtD
Polythiazide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00214	0.00214	CcSEcCtD
Polythiazide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00204	0.00204	CcSEcCtD
Polythiazide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00201	0.00201	CcSEcCtD
Polythiazide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Polythiazide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Polythiazide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00194	0.00194	CcSEcCtD
Polythiazide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00193	0.00193	CcSEcCtD
Polythiazide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00192	0.00192	CcSEcCtD
Polythiazide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Polythiazide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Polythiazide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00165	0.00165	CcSEcCtD
Polythiazide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00161	0.00161	CcSEcCtD
Polythiazide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00153	CcSEcCtD
Polythiazide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00148	0.00148	CcSEcCtD
Polythiazide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00143	CcSEcCtD
Polythiazide—Rash—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Polythiazide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Polythiazide—Headache—Prednisone—chronic obstructive pulmonary disease	0.0014	0.0014	CcSEcCtD
Polythiazide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
